Top Markets
#1 Threshold Network Threshold Network +65.04%
#2 TENDIES TENDIES +64.30%
#3 Cash Cat Cash Cat +22.24%
#4 OSK OSK +15.86%
#5 Magma Finance Magma Finance +13.64%
#6 Ape and Pepe Ape and Pepe +13.59%
#7 Asteroid Shiba Asteroid Shiba +13.00%
#8 Falcon Finance Falcon Finance +12.81%
#9 Kite Kite +12.56%
#10 龙虾 (Lobster) 龙虾 (Lobster) +11.22%
Coin of the day
Threshold Network Threshold Network
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Windlas Biotech Limited Windlas Biotech Limited

Windlas Biotech Limited

WINDLAS
Rang in Aktien #17116
Windlas Biotech Limited functions as a comprehensive contract development and... Windlas Biotech Limited functions as a comprehensive contract development and manufacturing organization (CDMO). Its CDMO offerings span the full product lifecycle, encompassing initial discovery, subsequent development, licensing, and large-scale commercial production of various generic pharmaceutical and nutraceutical items. Through these services, it assists clients in bringing both established and innovative pharmaceutical and nutraceutical products to market, which are then sold under the clients' proprietary brand names. Beyond its CDMO segment, Windlas Biotech also develops and manufactures its own portfolio of domestic trade generics and over-the-counter (OTC) brands, catering to the nutritional, ayurvedic, wellness, and personal care sectors. These in-house products reach consumers via a dual distribution approach: traditional offline channels like distributors, stockists, retail pharmacies, and institutional tenders, alongside a robust online presence through various e-commerce platforms. The company's international reach extends through exports, primarily to markets such as Vietnam, Myanmar, Sri Lanka, Thailand, the Philippines, Cambodia, Fiji, Trinidad & Tobago, and South Africa. Established in 2001, Windlas Biotech is headquartered in Gurugram, India.
Aktienkurs
$12.15
Marktkapitalisierung
$257.09M
Veränderung (1 Tag)
10.00%
Veränderung (1 Jahr)
9.99%
Land
IN
Handel Windlas Biotech Limited (WINDLAS)

Kategorie

Healthcare
Kursverlauf für Windlas Biotech Limited (WINDLAS)
Höchster Schlusskurs: $11.59 am 2026-09-01

Niedrigster Schlusskurs: $4.97 am 2021-08-01
Kursverlauf der Aktie von Windlas Biotech Limited von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 8.60%
2025 -30.97%
2024 149.05%
2023 63.15%
2022 -15.79%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 $171.67 -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 $164.22 30.66%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 $38.13 25.43%
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $21.28 19.62%
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 $214.53 25.84%
CH